These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 29352597)
1. Potential drug targets in the Mycobacterium tuberculosis cytochrome P450 system. Ortiz de Montellano PR J Inorg Biochem; 2018 Mar; 180():235-245. PubMed ID: 29352597 [TBL] [Abstract][Full Text] [Related]
2. Azole antifungals are potent inhibitors of cytochrome P450 mono-oxygenases and bacterial growth in mycobacteria and streptomycetes. McLean KJ; Marshall KR; Richmond A; Hunter IS; Fowler K; Kieser T; Gurcha SS; Besra GS; Munro AW Microbiology (Reading); 2002 Oct; 148(Pt 10):2937-2949. PubMed ID: 12368427 [TBL] [Abstract][Full Text] [Related]
3. [Research progresses of Mycobacterium tuberculosis cytochrome P450s as a potential drug target]. Lu Y; Qiao F; You XF; Yang XY Yao Xue Xue Bao; 2014 Apr; 49(4):427-34. PubMed ID: 24974457 [TBL] [Abstract][Full Text] [Related]
4. Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis. Munro AW; McLean KJ; Marshall KR; Warman AJ; Lewis G; Roitel O; Sutcliffe MJ; Kemp CA; Modi S; Scrutton NS; Leys D Biochem Soc Trans; 2003 Jun; 31(Pt 3):625-30. PubMed ID: 12773169 [TBL] [Abstract][Full Text] [Related]
5. The Mycobacterium tuberculosis cytochromes P450: physiology, biochemistry & molecular intervention. McLean KJ; Belcher J; Driscoll MD; Fernandez CC; Le Van D; Bui S; Golovanova M; Munro AW Future Med Chem; 2010 Aug; 2(8):1339-53. PubMed ID: 21426022 [TBL] [Abstract][Full Text] [Related]
6. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. Guardiola-Diaz HM; Foster LA; Mushrush D; Vaz AD Biochem Pharmacol; 2001 Jun; 61(12):1463-70. PubMed ID: 11377375 [TBL] [Abstract][Full Text] [Related]
7. Characterization of active site structure in CYP121. A cytochrome P450 essential for viability of Mycobacterium tuberculosis H37Rv. McLean KJ; Carroll P; Lewis DG; Dunford AJ; Seward HE; Neeli R; Cheesman MR; Marsollier L; Douglas P; Smith WE; Rosenkrands I; Cole ST; Leys D; Parish T; Munro AW J Biol Chem; 2008 Nov; 283(48):33406-16. PubMed ID: 18818197 [TBL] [Abstract][Full Text] [Related]
8. Structure-Function Analysis of the Essential Padayachee T; Lamb DC; Nelson DR; Syed K Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732102 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis cytochrome P450 enzymes: a cohort of novel TB drug targets. Hudson SA; McLean KJ; Munro AW; Abell C Biochem Soc Trans; 2012 Jun; 40(3):573-9. PubMed ID: 22616869 [TBL] [Abstract][Full Text] [Related]
10. Function, essentiality, and expression of cytochrome P450 enzymes and their cognate redox partners in Mycobacterium tuberculosis: are they drug targets? Ortega Ugalde S; Boot M; Commandeur JNM; Jennings P; Bitter W; Vos JC Appl Microbiol Biotechnol; 2019 May; 103(9):3597-3614. PubMed ID: 30810776 [TBL] [Abstract][Full Text] [Related]
11. Cholesterol ester oxidation by mycobacterial cytochrome P450. Frank DJ; Madrona Y; Ortiz de Montellano PR J Biol Chem; 2014 Oct; 289(44):30417-30425. PubMed ID: 25210044 [TBL] [Abstract][Full Text] [Related]
12. Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. McLean KJ; Munro AW Drug Metab Rev; 2008; 40(3):427-46. PubMed ID: 18642141 [TBL] [Abstract][Full Text] [Related]
13. Structure Based Discovery of Inhibitors of CYP125 and CYP142 from Mycobacterium tuberculosis. Katariya MM; Snee M; Tunnicliffe RB; Kavanagh ME; Boshoff HIM; Amadi CN; Levy CW; Munro AW; Abell C; Leys D; Coyne AG; McLean KJ Chemistry; 2023 May; 29(29):e202203868. PubMed ID: 36912255 [TBL] [Abstract][Full Text] [Related]
14. A comparison of steroid and lipid binding cytochrome P450s from Mycobacterium marinum and Mycobacterium tuberculosis. Child SA; Ghith A; Bruning JB; Bell SG J Inorg Biochem; 2020 Aug; 209():111116. PubMed ID: 32473484 [TBL] [Abstract][Full Text] [Related]
15. Substrate and reaction specificity of Mycobacterium tuberculosis cytochrome P450 CYP121: insights from biochemical studies and crystal structures. Fonvielle M; Le Du MH; Lequin O; Lecoq A; Jacquet M; Thai R; Dubois S; Grach G; Gondry M; Belin P J Biol Chem; 2013 Jun; 288(24):17347-59. PubMed ID: 23620594 [TBL] [Abstract][Full Text] [Related]
16. Structure, function and drug targeting in Mycobacterium tuberculosis cytochrome P450 systems. McLean KJ; Dunford AJ; Neeli R; Driscoll MD; Munro AW Arch Biochem Biophys; 2007 Aug; 464(2):228-40. PubMed ID: 17482138 [TBL] [Abstract][Full Text] [Related]
18. CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen. McLean KJ; Dunford AJ; Sabri M; Neeli R; Girvan HM; Balding PR; Leys D; Seward HE; Marshall KR; Munro AW Biochem Soc Trans; 2006 Dec; 34(Pt 6):1178-82. PubMed ID: 17073780 [TBL] [Abstract][Full Text] [Related]